Utilizing Opportunistic Computed Tomography Imaging to Refine Lean Body Weight Estimates in Patients with Obesity
Clinical Pharmacokinetics · 2025
DOI: 10.1007/s40262-025-01530-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacokinetics, 2025. Verfasst von Radin Alikhani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, 428 Church St, Ann Arbor, MI, 48108, USA. Hauptthemen laut MEDLINE: Tomography, X-Ray Computed, Obesity, Body Weight. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, Michigan Nutrition Obesity Research Center, Medical School, University of Michigan.
Abstract (Originalsprache)
INTRODUCTION: While dual-energy X-ray absorptiometry (DEXA) is the gold standard for measuring lean body weight (LBW), computed tomography (CT) provides muscle composition and distribution metrics that can refine LBW for better weight-based dosing. We explored how existing computed tomography (CT) images could be utilized to better estimate LBW. METHODS: Sixty-three adult patients (71.4% female) with a median age of 53.4 years and mean BMI of 36.84 having both DEXA and CT scans were retrospectively analyzed to assess the relationship between CT-based skeletal muscle variables and DEXA-derived LBW. RESULTS: Linear regression results revealed significant correlations. CT-derived skeletal muscle area (SMA) strongly predicted DEXA-derived LBW (p value < 0.05 and R2 between 0.67 and 0.80) at four different vertebra levels. DEXA-derived LBW showed a strong correlation with a height, weight, and sex-based estimate of LBW using an equation developed in 2005 (LBW2005). A final model incorporating SMA with the LBW2005 equation improved the coefficient of determination at all four vertebra levels (R2 0.82-0.86). DISCUSSIONS/CONCLUSION: This study demonstrates opportunistic CT scan data may improve an existing equation for LBW that has been predictive of select drug pharmacokinetic parameters. Improving LBW estimation may enable improved personalized drug dosing strategies in patients with obesity and other populations that benefit from using LBW over total body weight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, 428 Church St, Ann Arbor, MI, 48108, USA.
- Michigan Clinical Outcomes Research and Reporting Program, University of Michigan, Ann Arbor, MI, USA.
- Department of Internal Medicine-Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, USA.
- Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, 428 Church St, Ann Arbor, MI, 48108, USA. amitpai@umich.edu.
ORCID-Profile: Radin Alikhani, Steven Horbal, Amy E Rothberg, Manjunath P Pai
Förderung
- NIDDK NIH HHS
- Michigan Nutrition Obesity Research Center, Medical School, University of Michigan
Zitieren
APA
Alikhani, R., Horbal, S., Rothberg, A. E., & Pai, M. P. (2025). Utilizing Opportunistic Computed Tomography Imaging to Refine Lean Body Weight Estimates in Patients with Obesity. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-025-01530-3
Vancouver
Alikhani R, Horbal S, Rothberg AE, Pai MP. Utilizing Opportunistic Computed Tomography Imaging to Refine Lean Body Weight Estimates in Patients with Obesity. Clinical Pharmacokinetics. 2025. doi:10.1007/s40262-025-01530-3
BibTeX
@article{Alikhani2025,
author = {Alikhani, Radin and Horbal, Steven and Rothberg, Amy E and Pai, Manjunath P},
title = {Utilizing Opportunistic Computed Tomography Imaging to Refine Lean Body Weight Estimates in Patients with Obesity},
journal = {Clinical Pharmacokinetics},
year = {2025},
doi = {10.1007/s40262-025-01530-3}
}
EUVIMED